Report AL182C77837807491833 2023 07 07 R L
Report AL182C77837807491833 2023 07 07 R L
Report AL182C77837807491833 2023 07 07 R L
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS
Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical
for building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic
syndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.
Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.
Kit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.
Method : FULLY AUTOMATED CHEMI LUMINESCENT IMMUNO ASSAY
VITAMIN B-12 C.L.I.A 357 pg/mL
Reference Range :
Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs
and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For
diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and
other findings.
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 3.96 mg/L
Reference Range :-
Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as infection ,
active arthritis or concurrent illness.
Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk for
future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP tests, ideally
taken two weeks apart.
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS
TESTOSTERONE C.L.I.A 20.01 ng/dL
Reference Range :-
Adult Male
21 - 49 Yrs : 164.94 - 753.38 || 50 - 89 Yrs : 86.49 - 788.22
Adult Female
Pre-Menopause : 12.09 - 59.46 || Post-Menopause: < 7.00 - 48.93
Boys
2-10 Years : < 7.00 - 25.91
11 Years : < 7.00 - 341.53
12 Years : < 7.00 - 562.59
13 Years : 9.34 - 562.93
14 Years : 23.28 - 742.46
15 Years : 144.15 - 841.44
16-21 Years : 118.22 - 948.56
Girls
2-10 Years : < 7.00 - 108.30
11-15 Years : < 7.00 - 48.40
16-21 Years : 17.55 - 50.41
Clinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major
causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,
Hypopituitarism some types of liver and kidney diseases and critical illness.
Specifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.
Kit Validation Reference: Kicklighter EJ, Norman RJ. The gonads. In: Kaplan LA, Pesce AJ, eds. Clinical Chemistry: Theory, Analysis,
Correlation. 2nd ed. St. Louis: CV Mosby; 1989:657–662.
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
TOTAL CHOLESTEROL PHOTOMETRY 221 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 58 mg/dL 40-60
HDL / LDL RATIO CALCULATED 0.43 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 135 mg/dL < 100
TRIG / HDL RATIO CALCULATED 1.79 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 103 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 3.8 Ratio 3-5
LDL / HDL RATIO CALCULATED 2.3 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 163.04 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 20.65 mg/dL 5 - 40
Please correlate with clinical conditions.
Method :
CHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE
HCHO - DIRECT ENZYMATIC COLORIMETRIC
HD/LD - Derived from HDL and LDL values.
LDL - DIRECT MEASURE
TRI/H - Derived from TRIG and HDL Values
TRIG - ENZYMATIC, END POINT
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
ALKALINE PHOSPHATASE PHOTOMETRY 101.34 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.6 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.51 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 40.87 U/L < 38
SGOT / SGPT RATIO CALCULATED 1.08 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 21.65 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 20.1 U/L < 34
PROTEIN - TOTAL PHOTOMETRY 8.05 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.78 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 4.27 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 0.89 Ratio 0.9 - 2
Please correlate with clinical conditions.
Method :
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
UREA (CALCULATED) CALCULATED 47.57 mg/dL Adult : 17-43
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 22.23 mg/dL 7.94 - 20.07
UREA / SR.CREATININE RATIO CALCULATED 51.71 Ratio < 52
CREATININE - SERUM PHOTOMETRY 0.92 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 24.16 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 9.42 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 6.38 mg/dL 3.2 - 6.1
SODIUM I.S.E 138.1 mmol/L 136 - 145
CHLORIDE I.S.E 98 mmol/L 98 - 107
Please correlate with clinical conditions.
Method :
UREAC - Derived from BUN Value.
BUN - KINETIC UV ASSAY.
UR/CR - Derived from UREA and Sr.Creatinine values.
SCRE - CREATININE ENZYMATIC METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD
SOD - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE
PATIENTID : GG15114674
Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
USTSH - Third Generation Ultrasensitive Chemi Luminescent Immuno Assay
Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 70 mL/min/1.73 m2
Reference Range :-
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate
kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate
glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum
creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice,
instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the
doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining.
Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and
management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate.
Ann Intern Med. 2009;150(9):604-12.
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 5.7 %
Reference Range :
PATIENTID : GG15114674
TEST NAME TECHNOLOGY VALUE UNITS
FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 103.61 mg/dL
Reference Range :-
Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD
~~ End of report ~~
Page : 13 of 14
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
Page : 14 of 14